Cardinal Health (NYSE:CAH) Upgraded by Wall Street Zen to Strong-Buy Rating

Cardinal Health (NYSE:CAH) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Sunday.

Several other equities research analysts have also issued reports on CAH. Weiss Ratings lowered shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research note on Tuesday, May 19th. Morgan Stanley lifted their price target on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. JPMorgan Chase & Co. lowered their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Finally, TD Cowen raised their price objective on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $241.80.

Cardinal Health Price Performance

NYSE:CAH opened at $205.79 on Friday. The company has a 50 day moving average price of $202.53 and a 200-day moving average price of $208.57. Cardinal Health has a 1-year low of $137.75 and a 1-year high of $233.60. The firm has a market cap of $48.20 billion, a price-to-earnings ratio of 31.47, a price-to-earnings-growth ratio of 1.12 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts anticipate that Cardinal Health will post 10.76 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of CAH. Redhawk Wealth Advisors Inc. boosted its holdings in Cardinal Health by 0.5% in the 4th quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock worth $1,902,000 after buying an additional 48 shares during the last quarter. HF Advisory Group LLC lifted its position in shares of Cardinal Health by 0.9% in the fourth quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after acquiring an additional 49 shares in the last quarter. Kathmere Capital Management LLC boosted its stake in shares of Cardinal Health by 1.2% in the first quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock worth $896,000 after acquiring an additional 49 shares during the last quarter. Hillsdale Investment Management Inc. boosted its stake in shares of Cardinal Health by 0.9% in the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after acquiring an additional 50 shares during the last quarter. Finally, V Square Quantitative Management LLC increased its position in shares of Cardinal Health by 2.6% during the first quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock worth $423,000 after purchasing an additional 50 shares in the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.